While DNMT3B mutations are rarely detected in hematopoietic malignancies (27–29), DNMT3A mutations are very common in patients with clonal hematopoiesis and/or myeloid malignancies, and also cause the DNMT3A overgrowth syndrome (DOS). This evidence concerns the gene DNMT3A and overgrowth syndrome.